NASDAQ: AMGN - Amgen

Rentabilité sur six mois: -3.84%
Rendement en dividendes: +2.92%
Secteur: Healthcare

Nouvelles Télégramme

FTC sues to stop Amgen’s $27.8B deal for Horizon Therapeutics

18 novembre 17:52 FTC sues to stop Amgen’s $27.8B deal for Horizon Therapeutics

Biden pushes Congress to allow Medicare to negotiate drug prices

18 novembre 16:20 Biden pushes Congress to allow Medicare to negotiate drug prices